| NCCN Guidelines Update Webinar Series™ Kidney Cancer program overview - UroToday |
|
|
UroTodayWith the FDA approvals of new agents for renal cell carcinoma, a paradigm shift has occurred in the way patients with renal cell carcinomas are treated. ... read more |